The Power of Daphnetin: Enhancing Nrf2 Signaling Pathway

Authors

  • Amir Modarresi Chahardehi Kimia Andisheh Teb Medical and Molecular Laboratory Research Co., Tehran, Iran
  • Negar Jamshidi Kimia Andisheh Teb Medical and Molecular Research Laboratory Co., Tehran, Iran
  • Nazanin Jamshidi Kimia Andisheh Teb Medical and Molecular Research Laboratory Co., Tehran, Iran
  • Darioush Ghasemi Kimia Andisheh Teb Medical and Molecular Research Laboratory Co., Tehran, Iran
  • Farrokh Modarresi Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.22034/LSSJ.2024.107

Keywords:

Daphnetin, Nrf2 pathway, Anti-inflammatory, Antioxidant, Therapeutic potential

Abstract

Chronic inflammation and oxidative stress are involved in a range of diseases. The Nrf2 pathway is crucial in controlling cellular defenses against stresses. Daphnetin (DAP), a compound derived from plants such as Daphne odora, has shown promise to activate Nrf2, a protein with potential therapeutic uses. This review examines how DAP influences the Nrf2 pathway, increasing genes that promote antioxidant and anti-inflammatory effects. We present preclinical evidence showcasing the effectiveness of DAP in several illness models linked to inflammation and oxidative stress. In addition, we investigate recent progress in altering the structure of DAP to increase its effectiveness and improve its pharmacological characteristics. Lastly, we address prospective areas of future study, highlighting the importance of clinical translation studies in fully realizing DAP's therapeutic benefits. In summary, this study highlights the potential of DAP as a natural Nrf2 activator, which has important implications for preventing and managing diseases.

Downloads

Published

2024-04-28

How to Cite

Modarresi Chahardehi, A., Jamshidi, N., Jamshidi, N., Ghasemi, D., & Modarresi, F. (2024). The Power of Daphnetin: Enhancing Nrf2 Signaling Pathway. Life Sciences Student Journal, 2(1), 28–38. https://doi.org/10.22034/LSSJ.2024.107

Issue

Vol. 2 No. 1 (2024): Vo2,No1,2024

Section

Articles

License

 Publisher's Own License

This work is licensed under the publisher's own license, which allows for sharing and use under specific conditions. Attribution is required; users must give appropriate credit to the original creator. Additionally, this license includes a No Commercial Usage clause, meaning that the work cannot be used for commercial purposes or for profit. Users are encouraged to share and adapt the content non-commercially, provided they adhere to these guidelines. Please ensure that you respect the terms of this license to promote a collaborative and respectful use of the work.